Our study identified six hub genes (RRM2, TOP2A, CCNB1, CDK1, BIRC5 and PBK) that are significantly associated with HCC and may serve as potential prognostic biomarkers or therapeutic targets in HCC. Here, CDK1 is linked to hepatocellular carcinoma.